ANGPTL3调节肝脏的果糖感知和新陈代谢
Meng Zhao1, Karen Y Linde-Garelli2, Zeyuan Zhang3
1Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Diabetes Research Center, Stanford University School of Medicine, Stanford, CA 94305, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, CA, Stanford, USA; Department of Animal Science, University of California Davis, CA, Davis, USA.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及增加的果糖代谢. 血管蛋白样3 (ANGPTL3) 作为细胞外调节剂,感知果糖并控制其在肝脏中的吸收.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 生物化学 生物化学
背景情况:
- 果糖代谢与代谢功能障碍相关的脂肪性肝病 (MASLD) 有关.
- 控制肝脏果糖吸收的调节机制尚不清楚.
- MASLD肝脏显示果糖衍生的碳的吸收增加.
研究的目的:
- 调查MASLD中肝脏果糖代谢的调节机制.
- 为了确定新型调节器的果糖吸收和新陈代谢在肝脏.
- 阐明安吉奥波伊类3 (ANGPTL3) 在果糖代谢中的作用.
主要方法:
- 用分离和非向蛋白质组来识别关键蛋白质.
- 在体内研究中,Angptl3在肝脏中被淘汰.
- 测量包括果糖代谢物吸收和果糖载体和酶基因的表达.
主要成果:
- MASLD肝细胞分泌体增强了果糖的新陈代谢.
- ANGPTL3被确定为肝脏果糖代谢的调节者,独立于其抑制脂蛋白脂酶 (LPL) 的功能.
- 循环中的ANGPTL3水平随着果糖暴露而上升,这表明它作为果糖传感器的作用.
- Angptl3 knockdown 降低了肝脏的果糖代谢物吸收,并降低了GLUT8和果糖分解酶的调节.
结论:
- ANGPTL3在调节肝脏果糖代谢方面发挥着至关重要的作用.
- 通过ANGPTL3存在肝脏果糖代谢的细胞外控制.
- ANGPTL3代表了MASLD的潜在治疗标.
更多相关视频
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
Glycolysis: Preparatory Phase
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Insulin: The Receptor and Signaling Pathways
